APPLICATION
Application Note
IHC-P: orking dilution: Ready-to-use for 30 min at RTNo special pretreatment is required for histochemical staining of formalin/paraffin tissues. Optimal dilutions/concentrations should be determined by the end user.
Calculated MW
Positive Control
HUVEC cells. Breast carcinoma.
PROPERTIES
Form
Liquid
Buffer
PBS, 1% BSA
Preservative
0.1% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE.
Antigen Species
Human
Immunogen
Recombinant full length protein (Human).
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
thymidine phosphorylase , ECGF , ECGF1 , MEDPS1 , MNGIE , MTDPS1 , PDECGF , TP , hPD-ECGF
Background
This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
Database
Research Area
REFERENCE
There are currently no references for Thymidine Phosphorylase antibody [SPM322] (Ready-to-use) (GTX17806). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for Thymidine Phosphorylase antibody [SPM322] (Ready-to-use) (GTX17806). Be the first to share your experience with this product.